AXSM CIK: 1579428

Axsome Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.25
FY23:
0.50
FY24:
0.49
FY25:
0.59
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.09
FY23:
0.08
FY24:
0.08
FY25:
0.10
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.33
FY23:
0.59
FY24:
0.57
FY25:
0.69

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.10
FY23:
0.14
FY24:
0.23
FY25:
0.38
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.13
FY23:
0.26
FY24:
0.28
FY25:
0.22
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.11
FY23:
0.19
FY24:
0.06
FY25:
0.09
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.33
FY23:
0.59
FY24:
0.57
FY25:
0.69

All amounts in billions USD Data sources:SEC EDGARTwelve Data